Delivery Order SPE2DE23D0008-SPE2D625F3VJH
Award Date 9/11/25
Potential Completion Date 9/22/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,425.00 for Natrelle Inspira SCM 560CC breast implants by the Defense Logistics Agency Medical Supply Chain, a Defense agency division. The award, issued on August 14, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The contract was awarded without set-aside designation, reflecting Allergan's status as a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for Natrelle TE Smooth 133S breast implants. The contract, awarded on August 19, 2025, with an ultimate completion date of August 21, 2025, represents a child order under one of Allergan's two significant Indefinite Delivery Vehicles established with DLA Troop Support Medical. This $13.5 million IDV, awarded on December 8, 2022, supports...